实用肝脏病杂志 ›› 2018, Vol. 21 ›› Issue (1): 104-107.doi: 10.3969/j.issn.1672-5069.2018.01.025

• 肝癌 • 上一篇    下一篇

不同肝血流阻断方案对手术切除原发性大肝癌患者治疗效果比较

韩玉龙, 苗健, 尹家俊   

  1. 116001 辽宁省大连市 大连大学附属中山医院肝胆胰腹腔镜外科(韩玉龙,尹家俊);
    大连医科大学附属第二医院肝胆外二科(苗健)
  • 收稿日期:2017-03-15 出版日期:2018-01-10 发布日期:2018-01-29
  • 作者简介:韩玉龙,男,41岁,医学硕士,副主任医师。主要从事肝胆外科研究。E-mail:hylhanyulong@souhu.com

Comparison of different hepatic inflow occlusion in hepatectomy in treatment of patients with primary large liver cancer

Han Yulong, Miao Jian, Yin Jiajun   

  1. Department of Hepatobillary Laparoscopic Surgery,Zhongshan Hospital,Affilated to Dalian University,Dalian 116001,Liaoning Province
  • Received:2017-03-15 Online:2018-01-10 Published:2018-01-29

摘要: 目的 探讨不同肝血流阻断方法对外科手术切除原发性大肝癌患者疗效的影响。方法 2014年5月~2016年5月收治的172例原发性大肝癌患者,分别采用肝门阻断(n=52)、半肝阻断(n=44)和联合阻断(n=76)血流行肝癌切除术。结果 三组患者的基本资料比较差异无统计学意义(P>0.05);三组血流阻断时间、手术用时和切除肝量差异均无统计学意义(P>0.05),肝门阻断组出血量为(736.38±498.36) ml,显著多于半肝阻断组[(472.56±111.89) ml或联合阻断组的(356.14±132.53) ml,P<0.05],肝门阻断组输血量为(586.54±132.58) ml,显著多于半肝阻断组[(427.95±210.47) ml或联合阻断组的(184.38±72.54) ml,P<0.05];术后7 d,肝门阻断组血清ALT水平为(73.02±43.41) U/L,显著高于半肝阻断组[(55.89±40.82) U/L或联合阻断组的(52.01±33.81) U/L,P<0.05];三组手术并发症以肺部感染、切口感染、胆瘘、腹腔积液为主,但其发生率差异无统计学意义(P>0.05);联合阻断组1 a生存率为96.1%,肿瘤复发率为2.6%,显著低于肝门阻断组的75.0%和15.4%或半肝阻断组的68.2%和20.5%(P<0.05)。结论 Pringle法联合肝下腔静脉阻断术阻断血流在切除原发性大肝癌患者外科手术过程中可以有效降低术中出血量,促进患者术后恢复,或许还能提高生存率。

关键词: 原发性肝癌, 血流阻断, 肝叶切除术, 生存

Abstract: Objective To investigate the efficacy of different hepatic inflow occlusion in hepatectomy in treatment of patients with primary large liver cancer. Method 172 patients with primary large liver cancer in our hospital and in Second Hospital affiliated to Dalian Medical University between May 2014 and May 2016 were divided into three groups according to the different methods of blood flow occlusion during hepatectomy. 52 cases received portal occlusion,44 cases received hemihepatic occlusion,and 76 cases received combination occlusion. The relevant clinical parameters among the three groups were compared. Results There was no significant differences in baseline data among the three groups (P>0.05);there was no significant differences in blocking time, operation time and hepatic resection volumes among the three groups(P>0.05);the amounts of bleeding in portal occlusion group was(736.38±498.36) ml,much more excessive than[(472.56±111.89) ml in hemihepatic occlusion group or (356.14±132.53) ml in combination occlusion group,P<0.05],and the blood transfusion volumes in portal occlusion group was (586.54±132.58)ml,much more massive than [(427.95±210.47) ml in hemihepatic occlusion group or(184.38±72.54) ml in combination occlusion group,P<0.05];7 days after operations,serum ALT level in portal occlusion group was(73.02±43.41)U/L,much higher than[(55.89±40.82) U/L in hemihepatic occlusion group,or (52.01±33.81) U/L in combination occlusion group (P<0.05);there was no significant differences as respect to complication rate among the three groups(P>0.05);the 1 a survival rate in combination group was 96.1% and the tumor relapse rate was 2.6%,much lower than 75.0% and 15.4% in portal occlusion group or 68.2% and 20.5%,respectively,in hemihepatic occlusion group(P<0.05). Conclusion The application of Pringle method combined with inferior vena cava occlusion in blocking hepatic blood flow during hepatectomy in treatment of patients with primary large liver cancer can effectively reduce the amount of intraoperative bleeding,improve recovery,and might increase survivals.

Key words: Hepatoma, Hepatectomy, Hepatic inflow occlusion, Survival